baber/WOPTO huggingface dataset:
Patent DE-69415134-T2 (DE)
Inventor: NELSEN JAMES
IPC: B60R21/237
Filed: 1994-06-17
Granted: 1999-04-29
Abstract: An apparatus and method for making a low cost, self-venting, inflatable protective cushion of simple and structurally efficient design with a shape and construction that optimizes the cushion's ability to withstand inflation pressures and impact when deployed which includes a sheet defined by at least one fold line and a plurality of flap portions, each flap portion having a base edge corresponding to a fold line and at least two side edges each extending outwardly from a base edge and ultimately converging to meet each other, the flap portions being folded at the fold line(s) and being joined at corresponding side edges to define an inflatable chamber. The inflatable protective cushion and method for making same may further include a lightweight, low permeability, fabric that optimizes the cushion's ability to withstand inflation pressures and impact when deployed and minimizes the packed volume of the cushion when stored.
Patent DE-69424734-T2 (DE)
Inventor: KUO ELIZABETH ANNE
IPC: A61P29/00
Filed: 1994-09-29
Granted: 2000-11-16
Abstract: The compounds of formula (I): <IMAGE>  [in which   R1 represents a hydrogen atom or an alkyl group containing 1 to 3 carbon atoms;   R2 represents a cycloalkyl group containing 3 to 6 carbon atoms; R4 represents a halogen atom, a nitrile group, a nitro group, an -SCH3 group, a C1-6 alkylcarbonyl group, a C3-6 cycloalkylcarbonyl group, a -CX3 group, a -WCX3 group, a -(CH2)nCX3 group, a -(CX2)n CX3 group, a -W(CX2)nCX3 group or a -W(CH2)nCX3 group, in which X represents a halogen atom, W represents an oxygen or sulphur atom and n represents 1, 2 or 3; and R5 represents a hydrogen atom, an alkyl group containing 1 to 3 carbon atoms or a cycloalkyl group containing 3 to 6 carbon atoms; provided that, if R5 represents a hydrogen atom, R4 does not represent an -SCH3 or -CF3 group]; and their salts have an anti-proliferative, anti-inflammatory and anti-tumour activity. A description is also given of processes for their preparation, of the compositions which contain them and of their use in therapeutics.
Patent DE-69426602-T2 (DE)
Inventor: IKEDA YOSHIHARU
IPC: C07C311/06
Filed: 1994-10-11
Granted: 2001-08-30
Abstract: A 2,3-diaminopropionic acid derivative represented by general formula (1) or a pharmaceutically acceptable salt thereof. This compound is useful as a platelet aggregation inhibitor, cancer metastasis inhibitor, wound remedy or bone resorption inhibitor. <CHEM>
Patent DE-69433895-T2 (DE)
Inventor: WARD IRL E
IPC: H01L21/027
Filed: 1994-11-30
Granted: 2005-07-28
Abstract: An aqueous stripping composition comprising a mixture of about 55% to 70% by weight of monoethanolamine, about 22.5 to 15% by weight of hydroxylamine and water. The stripping composition is effective to strip photoresists, residues from plasma process generated organic, metal-organic materials, inorganic salts, oxides, hydroxides or complexes in combination with or exclusive of organic photoresist films at low temperatures without redepositing any substantial amount of metal ions.
Patent DE-69510745-T2 (DE)
Inventor: TALIEH HOMAYOUN
IPC: B24B37/20
Filed: 1995-10-11
Granted: 1999-12-09
Abstract: A semi-conductor wafer polishing machine (10) having a polishing pad assembly (14) and a wafer holder (12) includes a support (24) positioned adjacent the polishing pad assembly (14). The support (24) includes multiple fluid bearings (34) that support the polishing pad assembly (14) on the support (24). These fluid bearings (34) are arranged concentrically to provide concentric regions of support for the polishing pad assembly (14), and each fluid bearing (34) is coupled to a respective source of pressurized fluid at a respective pressure. <IMAGE>
Patent DE-69523758-T2 (DE)
Inventor: VIRKKI MARKKU
IPC: A23K30/18
Filed: 1995-06-07
Granted: 2002-08-01
Abstract: PCT No. PCT/FI95/00330 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Jun. 7, 1995 PCT Pub. No. WO96/00507 PCT Pub. Date Jan. 11, 1996The invention relates to the use of an organic acids containing fraction obtained from vinasses and molasses for preserving forage, stimulating microbial growth and activity, and enhancing forage utilization. The fraction may be used as such, or mixed with forage, or used together with a microbe that resists the acidity of the fraction and produces acid.
Patent DE-69527690-T2 (DE)
Inventor: OMATA KOUICHI
IPC: B41J2/05
Filed: 1995-11-07
Granted: 2003-04-03
Abstract: An ink jet recording method for recording by use of an ink jet head, which is provided with a plurality of elemental substrates having a plurality of discharge energy generating elements arranged in line, the substrates being arranged in the direction of such line, comprises the step of selecting adjacent discharge energy generating elements between adjacent elemental substrates to be ready for driving simultaneously or continuously, or the step of shifting the position to start the driving cycle for the discharge energy generating elements from the respective seamed portions between the elemental substrates, hence reducing the unevenness of prints brought about on the seamed portions between elemental substrates. <IMAGE>
Patent DE-69531086-T2 (DE)
Inventor: MCKENZIE E
IPC: A61K38/42
Filed: 1995-03-27
Granted: 2004-04-01
Abstract: Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode. Additional benefits include a reduction in the number of post-ischemic arrhythmias, reduction in the incidence of restenosis, and improved contractile function in the area of risk.
Patent DE-69533553-T2 (DE)
Inventor: MENSAH KOFI
IPC: A01N63/32
Filed: 1995-09-26
Granted: 2005-11-24
Abstract: A method of controlling moth and other insect pests in a habitat and attracting, augmenting or conserving natural enemies of the moth or other insect pests, which comprises treating the habitat with yeast.
Patent DE-69534963-T2 (DE)
Inventor: PARRISH K
IPC: A01N43/50
Filed: 1995-11-27
Granted: 2006-12-21
Abstract: A herbicidal composition comprising a sulfonylurea derivative of formula (I) <CHEM> wherein Q is -CH=CH- or -S-, R is straight or branched C1-3 alkyl, and X is -OCH3 or -CH3, or an agriculturally acceptable salt thereof, and at least one co-herbicide selected from *     imidazolinone herbicides,   diphenyl ether herbicides,   hydroxybenzonitrile herbicides, 2-(4-aryloxyphenoxy) alkanoic acid herbicides and oxime herbicides,    carbamate and thiocarbamate herbicides,   quaternary ammonium salt herbicides,   triazole herbicides, phytohormone herbicides, including aryloxyalkanoic acid herbicides, arenecarboxylic acid herbicides, pyridinecarboxylic acid herbicides, and pyridyloxyacetic acid herbicides,   2, 6-dinitroaniline herbicides,   amide herbicides, and   anilide herbicides, the respective herbicidal constituents being present in amounts such that the compositions display selectivity of herbicidal action with respect to crops being treated pre- or post-emergent and exhibit synergistic effects when applied at herbicidally effective rates.
Patent DE-69600881-T2 (DE)
Inventor: OSTER JAN
IPC: H04N5/335
Filed: 1996-06-21
Granted: 1999-06-10
Abstract: An imaging system and method which successively records parts of a single frame image compensates for variations in intensity of an illuminating source such that the recorded single frame image appears to have been generated by a substantially temporally constant light intensity. This compensation allows inexpensive light sources and detectors to be employed.
Patent DE-69607478-T2 (DE)
Inventor: LANGE JOERN ANKER
IPC: B29C67/00
Filed: 1996-06-19
Granted: 2000-10-26
Abstract: PCT No. PCT/DK96/00265 Sec. 371 Date Jun. 2, 1998 Sec. 102(e) Date Jun. 2, 1998 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/19772 PCT Pub. Date Jun. 5, 1997The method comprises the production of a first positive model of an item to be cast. The positive model is produced with a flange extending in an imaginary separation line of the item. The flange extends both inwardly in the item within an outer periphery of the item and outwardly outside the outer periphery of the item. The flange establishes an artificial increase of the thickness of the item. Through different intermediate steps at least a first mould part and a second mould part of a mould are produced. The first and the second mould part of the mould initially have a separation zone forming a contact surface between the first and the second mould part. The mould parts are treated in the separation zone so that the negative moulds of an upper and a lower surface of the part of the flange extending outside the item will subsequently form a contact surface of the first and the second mould part. The advantage of the method is a fast and easy production of moulds for complicated item geometries and different joint surface conditions as well as moulds having considerably better mould tolerances than known moulds produced traditionally, e.g. by means of stereo lithography.
Patent DE-69612871-T2 (DE)
Inventor: FORTE LUIGI
IPC: C07J71/00
Filed: 1996-12-04
Granted: 2001-10-04
Abstract: PCT No. PCT/EP96/05390 Sec. 371 Date Jun. 5, 1998 Sec. 102(e) Date Jun. 5, 1998 PCT Filed Dec. 4, 1996 PCT Pub. No. WO97/21722 PCT Pub. Date Jun. 19, 1997A process for preparing the compound (11 beta ,16 beta )-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (INN deflazacort) which comprises reacting (11 beta ,16 beta )-11,21 -dihydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione with acetic anhydride in a suitable organic solvent in the presence of a basic catalyst and water.
Patent DE-69614411-T2 (DE)
Inventor: LACK LLOYD
IPC: C10L1/12
Filed: 1996-12-26
Granted: 2002-06-06
Abstract: A composition for enhancing combustion of hydrocarbon fuels such as LPG, gasoline and diesel fuel comprises at least one metal oxide catalyst dispersed in a liquid organic carrier compatible with the hydrocarbon fuel. The metal oxide catalyst preferably includes at least one of chromium oxide, magnesium oxide, manganese oxide, cobalt oxide, iron oxide and mixtures thereof; and the liquid organic carrier preferably includes Stoddard solvent together with at least one of a high temperature lubricant, a surfactant, and a polar organic solvent. The composition permits the hydrocarbon fuel to be combusted substantially completely so as to reduce emissions associated with incomplete oxidation, and also permits the combustion to occur at lower temperatures for avoiding formation of NOx.
Patent DE-69615869-T2 (DE)
Inventor: LITERATI NAGY PETER
IPC: A01N43/40
Filed: 1996-12-20
Granted: 2002-04-11
Abstract: Compositions containing hydroximic acid derivatives of the formulawhere R1, R2, R3, R, X, Y, A, and B are as defined in the specification, are useful for the promotion of plant production and/or for the elimination of unfavourable environmental influences in plant cultivation.
Patent DE-69619979-T2 (DE)
Inventor: SETH PAWAN
IPC: A61K31/4965
Filed: 1996-04-15
Granted: 2002-11-21
Abstract: A solid composition containing a non-amorphous active principle combined with polyethyleneoxide and conventional additives but no basic components. Such compositions may be used as pharmaceutical compositions. A method for preparing said compositions is also disclosed.
Patent DE-69622031-T2 (DE)
Inventor: OKU TERUO
IPC: A61K31/535
Filed: 1996-04-02
Granted: 2002-12-12
Abstract: PCT No. PCT/JP96/00892 Sec. 371 Date Dec. 10, 1997 Sec. 102(e) Date Dec. 10, 1997 PCT Filed Apr. 2, 1996 PCT Pub. No. WO96/32379 PCT Pub. Date Oct. 17, 1996Compounds of the formula (I): and their pharmaceutically acceptable compositions are useful in inhibiting the activity of cyclic guanosine 3',5'-monophosphate phosphodiesterase.
Patent DE-69630342-T2 (DE)
Inventor: TSUTSUI KEIICHI
IPC: G11B7/085
Filed: 1996-08-01
Granted: 2004-08-19
Abstract: A disk driving device for use in recording and/or reproducing data on an optical recording medium having a plurality of recording layers. When a focus jump operation is executed between the recording layers, an actuator displaces an objective lens in response to a selectively generated acceleration or deceleration pulse and a focus error signal. Instability of the focus jump operation derived from noise superimposed on the focus error signal or from sensitivity variations in the actuator is eliminated. <IMAGE>
Patent DE-69632667-T2 (DE)
Inventor: LINSLEY PETER S
IPC: C12N5/0783
Filed: 1996-07-19
Granted: 2005-06-16
Abstract: The invention provides CTLA4 mutant molecules as ligands for the B7 antigen. Methods are provided for expressing CTLA4 mutant molecules as soluble, functional molecules, for preparing CTLA4 mutant fusion proteins, and for using these soluble molecules to regulate T cell interactions and immune responses mediated by such interactions. <IMAGE>
Patent DE-69708053-T2 (DE)
Inventor: LATVAKANGAS URPO
IPC: B42C9/00
Filed: 1997-01-22
Granted: 2002-07-04
Abstract: The present invention relates to a method, a device for assembling and producing of booklets. Each booklet having a cover that comprises two cover sheets and a spine disposed inbetween. A glue string is applied to the inner surface of the spine, and a sheet bundle inserted between the cover sheets of said cover and affixed at one end side edge to the inner surface of the spine by means of the glue string.
Patent DE-69709773-T2 (DE)
Inventor: ALAMI MOUAD
IPC: C07C255/50
Filed: 1997-09-17
Granted: 2002-08-08
Abstract: The subject-matter of the invention is a process for the preparation of substituted 4-methylbiphenyls of general formula:in which R is a cyano group or a protected tetrazolyl group of formula:in which R1, situated at the 1 or 2 position of the tetrazolyl group, is a protective group, characterized in that a halobenzene of formula:in which Hal is a halogen atom and R has the same meaning as above, is reacted with a p-tolylmagnesium halide in the presence of a linear or branched polyether and of a catalyst comprising a transition metal.
Patent DE-69710660-T2 (DE)
Inventor: LEGRAND DENIS
IPC: E06B3/663
Filed: 1997-09-10
Granted: 2002-08-14
Abstract: A method for assembling at least two envelope components (3,4) and between these elements at least one deformable component (5), in order to render these components integrally rigid in an irreversible manner, comprises: (a) arranging at least one first component (3) in an assembly position, with at least one first assembly surface accessible; (b) arranging at least one deformable component (5) with a first assembly surface facing the first assembly surface and a second intermediary assembly surface accessible, this deformable component (5) being provided with at least one compression pad (6) and/or at least one guard release; (c) possibly placing in this latter at least one built-up compression pad (6), facing the assembly surface of the first envelope component (3); (d) arranging at least one second envelope component (4) with at least one assembly surface facing at least one assembly surface of the deformable component (5) and/or at least one compression pad (6); and (e) effecting a binding treatment of a sort such that at least one compression pad (6) has its first assembly surface in contact with that of the first envelope component (3) and a second assembly surface of a compression pad (6) may be in contact with that of the second envelope component (4). The assembled components (3,4,5) are destined to be submitted to compression forces following a direction cutting, essentially perpendicular, at least one surface of the assembly. Also claimed are the assembly installation used to put this method into service, the device destined to be subjected to the compression forces and the assembly incorporating this device.
Patent DE-69711586-T2 (DE)
Inventor: D AMORE MICHEL
IPC: B21D51/26
Filed: 1997-11-26
Granted: 2002-10-02
Abstract: The method involves pressing a metal blank to form a rough shape (10) with a base (11) and a peripheral skirt (12). As second stage involves forming the peripheral skirt into a sidewall with a shaped section (5) in a shaping operation including a shortening and an extending mode. The third stage involves forming the skirt of the rough shape to obtain the sidewall of the can. The peripheral skirt of the rough shape can have a constant section over at least part of its height. The peripheral skirt can have a flared section.
Patent DE-69714391-T2 (DE)
Inventor: MISAWA RINTARO
IPC: B66B31/00
Filed: 1997-12-02
Granted: 2003-03-20
Abstract: A wheelchair transporter (1) for transporting a wheelchair on an escalator, comprises: a transporter main body (2) ; a pair of front wheels (3) and a pair of rear wheels (4), each of which is adapted to engage the bottom surface of a step on an escalator; a mounting structure (5) for mounting a wheelchair; an extending/retracting device connected with one end of the mounting structure (5) for pivoting the mounting structure (5) in vertical direction. An escalator control system for transporting a wheelchair transporter (1) on an escalator, comprises: a first to fourth light emitting detecting devices provided on an escalator; and a light reflecting plate provided on the wheelchair transporter (1) for reflecting a light emitted from one of the first to fourth light emitting detecting devices. <IMAGE>   <IMAGE>
Patent DE-69717840-T2 (DE)
Inventor: KILPATRICK DAVID
IPC: C12Q1/6844
Filed: 1997-10-01
Granted: 2003-09-04
Abstract: This invention provides sensitive nucleic acid hybridization assay methods for the detection of non-polio enterovirus nucleic acids. The methods are particularly useful in detecting the presence of enterovirus nucleic acids in a biological sample and for ascertaining the serotype of enteroviruses present in a sample.
Patent DE-69721183-T2 (DE)
Inventor: KURA JUMPEI
IPC: G11B20/14
Filed: 1997-10-24
Granted: 2004-02-26
Abstract: A digital signal reproduction circuit is capable of controlling a transfer function of a waveform equalization circuit so that a synchronous clock can be generated with an optimal transfer characteristic. The digital signal reproduction circuit (1) includes: a waveform equalization block (10) for waveform-equalizing a regenerative signal, a binarization block (20) for binarizing the waveform-equalized regenerative signal, a synchronous clock reproduction block (30) for generating a synchronous clock from the binarized signal, and a waveform equalization control block (40) for controlling a transfer function of the waveform equalization block (10) according to a jitter component between the synchronous clock and the binarized signal. The waveform equalization control block (40) is supplied with a phase difference signal between the binarized signal and the synchronous signal so as to obtain an optimal value of the transfer function of the waveform equalization block (10) by using a microcomputer, for example. The transfer function is controlled so as to reduce the jitter component of the synchronous clock. <IMAGE>
Patent DE-69726255-T2 (DE)
Inventor: DELEHANTY JOHN
IPC: A61K9/20
Filed: 1997-01-17
Granted: 2004-08-26
Abstract: The invention relates to the antiviral drug valaciclovir, the valine ester of 9-[(2-hydroxyethoxy)methyl]guanine (aciclovir), which is known as an effective treatment for genital herpes in a dosage regime of 40 mg, twice to 5 times daily. More specifically, the invention relates to a method for the suppression of recurrent genital herpes in a human host comprising administering to the host from about 200 mg to about 1000 mg valaciclovir or a pharmaceutically acceptable salt thereof once daily for an effective treatment period, as well as to the use of valaciclovir or a pharmaceutically acceptable salt thereof in the preparation of a unit dosage medicament for once daily administration in the suppression of recurrent genital herpes, and to a pharmaceutical composition for administration once daily in the suppression of genital herpes, comprising from 200 mg to 1000 mg valaciclovir or a pharmaceutically acceptable salt thereof, in unit dosage form. Particularly preferred unit dosage forms include tablets and capsules for oral administration. The preferred pharmaceutically acceptable salt of valaciclovir is the hydrochloride salt.
Patent DE-69802191-T2 (DE)
Inventor: RUDI KNUT
IPC: C12N15/09
Filed: 1998-05-13
Granted: 2002-06-06
Abstract: The present invention provides a method of isolating nucleic acid from a sample of cells, said method comprising: (a) binding cells in said sample in a solid support to isolate cells from the sample; (b) lysing the isolated cells; and (c) binding nucleic acid released from said lysed cells to said same solid support and a kit for carrying out such a method. The method may advantageously be used to prepare nucleic acid for use in a nucleic acid-based target cell detection method.
Patent DE-69807499-T2 (DE)
Inventor: BARCLAY JOHN
IPC: H04B1/707
Filed: 1998-01-16
Granted: 2003-01-02
Abstract: A signalling system is provided which can be used to update the prices of goods which are electronically displayed on supermarket shelves (1). The signalling system comprises a first signalling device having an input terminal for receiving electrical message data received from a central computer system (5), a spread spectrum encoder for encoding the received message data and an electroacoustic converter (11) for converting the encoded data into corresponding acoustic signals and for transmitting the acoustic signals into a transmission medium. The signalling system also comprises a second signalling device (3) having means for receiving acoustic signals from said transmission medium and for converting the received acoustic signals into corresponding electrical signals, a spread spectrum decoder for decoding the received signals and a message regenerator for regenerating the message data transmitted by the first signalling device from the signals output by the decoder. <IMAGE>
Patent DE-69812206-T2 (DE)
Inventor: MCKEOWN MARK WILLIAM
IPC: H04N7/173
Filed: 1998-04-16
Granted: 2003-11-27
Abstract: An interactive, predictive game control system for use in conjunction with a live TV broadcast received by one or more remote players (C). The system comprises a central controller (1) for generating game playing data for transmission with a TV broadcast to the remote player(s) and for receiving information from the remote player(s). An input device (2) is connected to the central controller (1). A database (4A) is connected to the central controller (1) for storing data relating to the content of the live broadcast and known in advance of the live broadcast. The central controller (1) is responsive to signals from the input device (2):   a) prior to the live broadcast, to select data from the database (4A) for transmission to the remote user(s) in advance of and/or during the live broadcast, and b) during or after the live broadcast, to record the time of occurrence of one or more events relating to the live broadcast which are to be predicted by the remote player(s), as indicated by an operator to the central controller (1) via the input device (2).   <IMAGE>
Patent DE-69832810-T2 (DE)
Inventor: HAUMONT SERGE
IPC: H04Q3/00
Filed: 1998-10-15
Granted: 2006-06-29
Abstract: The advantages of optimal routing are somewhat limited by the tariff requirements requiring that optimal routing must not cause the call to be more expensive to any of the subscribers participating in the call. If the bills of both the calling and the called subscriber are paid by the same company, for example, it is in the interest of the company to minimize the total cost of the call, i.e. the sum of the bills of subscribers A and B. In this invention a condition for bypassing the tariff requirement for direct routing is specified. The calls can be routed directly, for example, within a prespecified user group.</PTEXT>